6533b7d0fe1ef96bd125a615
RESEARCH PRODUCT
Clinical characteristics and outcomes of thymoma-associated myasthenia gravis
Carlos CasasnovasYolanda MorgadoMaría Teresa Gómez-caravacaLuis QuerolAlba Ramos-fransiHelena Pérez-pérezRodrigo ÁLvarez-velascoElisabeth MartínezVelina NedkovaJanina Turon-sansJuan Carlos TrujilloIvonne JericóEduard GallardoEduard GallardoRicard Rojas-garcíaGuillermo FernándezBeatriz Vélez-gómezAna L. Pelayo-negroSonia SegoviaAlicia Martínez-piñeiroElena Cortés-vicenteTeresa SevillaCarmen ParadasMaría Asunción MartínMaría Dolores MendozaAdolfo López De MunainMarina Arribas-velascoAntonio Guerrero-solaGerardo Gutiérrez-gutiérrezIsabel IllaJulio Pardosubject
medicine.medical_specialtyThymomaThymomaEnfermedad del sistema nerviosoMiastenia gravischemical and pharmacologic phenomenaGastroenterology03 medical and health sciences0302 clinical medicineDisease severityRecurrenceInternal medicinehemic and lymphatic diseasesMyasthenia GravismedicineHumansIn patient030212 general & internal medicineneoplasmsNeurologíaMyasthenia gravisRetrospective Studiesbusiness.industryHazard ratioOdds ratioThymus Neoplasmsthymomamedicine.diseaseThymectomyPrognosisConfidence intervalMyasthenia gravisThymomEfectos fisiológicossurgical procedures operativeNeurologyMulticenter studySignos y síntomasNeurology (clinical)Neoplasm Recurrence LocalbusinessTimoma030217 neurology & neurosurgerydescription
[Background and purpose] Prognosis of myasthenia gravis (MG) in patients with thymoma is not well established. Moreover, it is not clear whether thymoma recurrence or unresectable lesions entail a worse prognosis of MG.
year | journal | country | edition | language |
---|---|---|---|---|
2021-01-01 |